NAMSW

Conviction 38Scan · Mon, Aug 10, 2026

NAMSW$17.00+0.00%

ResistanceSupportVol 14

Vol MA14 317.143

May 8May 27Jun 15Jul 2Jul 22Aug 7

NewAmsterdam Pharma Co N.V.PHARMACEUTICAL PREPARATIONSwww.newamsterdampharma.com ↗

Price17.00

Change+0.00%

Gap—

Rel volume3.49×

Avg volume336

Avg $ vol5.93K

SMA 209.74

SMA 509.29

SMA 20010.53

Price vs 50+83.04%

Price vs 200+61.46%

MA stackmixed

50/200 cross—

Supertrendup · -1.25

RSI (14)53

MACD hist-0.04

MACD crossbear · 3d

Stoch %K / %D88 / 57

ADX (14)7

+DI / −DI53 / 46

RSI divergence—

MACD divergence—

ATR %+66.57%

ADR %4.30%

52w high29.99

52w low0.0000

From 52w high-43.31%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width364.94%

%B0.70

Donchian pos80.57%

Donchian high21.10

Donchian low0.0000

AVWAP (52w high)20.47

vs AVWAP high-16.96%

AVWAP (52w low)19.69

vs AVWAP low-13.66%

OBV trendUp

Chaikin MF (20)-0.38

Today vs 20d3.49×

Avg vol (14d)317

Avg vol (20d)336

Avg $ vol (20d)5.93K

Market cap—

RS 3m (vs SPY)-31.14%

RS 6m (vs SPY)-30.41%

RS line new highNo

Trend template2/8

Technical rank91.5

1 week—

1 month—

3 months-25.44%

6 months-16.30%

1 year+41.67%

YTD-26.41%

P/E-9.38

P/B3.03

P/S84.99

P/FCF-12.92

EPS-1.72

Div yield—

ROE-32.28%

ROA-28.93%

Debt/Eq—

Current9.03

EV/EBITDA-6.60

Gross margin—

Net margin-905.74%

Rev growth-50.61%

EPS growth15.64%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value1.49B

Revenue3.7M

Net income-64.14M

Gross profit—

Free cash flow-148.03M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out4.6M

Employees100

ListedWed, Nov 23, 2022

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction38 / 100

Pattern quality—

Tech rank91.5 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance24.17

Support0.0000

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NAMSW

All disclosures →

No recent disclosed trades by Congress in NAMSW. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NAMSW

No recent insider (Form 4) filings in NAMSW. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in NAMSW

EDGAR →

No recent SEC filings on file for NAMSW.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.